An oriP expression vector containing the HIV-1 Tat/TAR transactivation axis produces high levels of protein expression in mammalian cells
- 1 January 2001
- journal article
- Published by Springer Nature in Cytotechnology
- Vol. 37 (1) , 23-30
- https://doi.org/10.1023/a:1016124911071
Abstract
A mammalian gene expression vector based on cytomegalovirus (CMV)enhancer/promoter (CMVe/p) for the regulation of gene expression was further optimized by adding oriP elements derived from Epstein-Barr virus (EBV) and the Tat/TAR transactivation axisfrom human immunodeficiency virus type 1 (HIV-1). Using the Tat/TAR-oriP expression vector, a transient transfection system was optimized for an extended culture period to produce large amounts of secreted IL-2SA (an IL-2 mutein) in HKB11 cells. We observed a 4-fold increase in IL-2SA expression in cells transfected with vectors containing the HIV-1 transactivation axis (Tat/TAR) or oriP elements alone when compared to cells transfected with the control vector having a CMVe/p. Cells transfected with expression vectors equipped with both oriP and Tat/TAR showed an 18-fold increase in IL-2SA expression. This transient transfection system maintained high secretion of IL-2SA for a period of 10-day with no appreciable loss in expression. We demonstrate that during this 10-day culture period, it was possible to produce 1–100 mg of proteins using 500 μg of plasmid DNA.Keywords
This publication has 10 references indexed in Scilit:
- Construction of new amplifier expression vectors for high levels of IL-2 gene expression.International Journal of Molecular Medicine, 2000
- The Epstein–Barr virus nuclear protein SM is both a post-transcriptional inhibitor and activator of gene expressionProceedings of the National Academy of Sciences, 1998
- Epstein-Barr virus-derived vectors for transient and stable expression of recombinant proteins.1993
- A genetic element that increases the frequency of gene amplification.Journal of Biological Chemistry, 1991
- Tat trans-activates the human immunodeficiency virus through a nascent RNA targetCell, 1989
- Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses.Proceedings of the National Academy of Sciences, 1986
- Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus.Proceedings of the National Academy of Sciences, 1986
- A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.Proceedings of the National Academy of Sciences, 1984
- The E4 transcilpilonal unit of Ad2: far upstream sequences are required for its transactivation by E1ANucleic Acids Research, 1984
- Identification of a rare Epstein-Barr virus variant that enhances early antigen expression in Raji cells.Proceedings of the National Academy of Sciences, 1983